No useful tumor makers for renal cell carcinoma (RCC) have yet been established. In the present study, the serum IAP level was assessed sa a diagnostic and follow-up marker for RCC. The subject were 16 women Based on these results, it was concluded that IAP may be auseful marker for RCC, although it appears valuable for assessing the prognosis than for diagnosis. A more accurate assessment of the prognosis of RCC was possible using a combination of the IAP value and clinical stage.
Relationship between IAP levels and the prognosis
The patients were divided into the following three at the time of diagnosis were evaluated first. The normal group had a significantly better survival than the slightly elevated and elevated groups (p<0.01 for both groups).
Additionally, the survival rate of the slightly elevated group was also significantly better than that of the elevated group (p<0.05) (Fig. 3 ).
In the high stage RCC patients, the survival rate of the normal group was significantly better than that of the slightly elevated or elevated groups (p<0.01 for both groups), while there was no difference in survival between the slightly elevated and elevated groups (Fig.   4 ). In the low stage patients, the survival rate of the elevated group was significantly worse than that of the slightly elabated or normal groups (p<00.1) (Fig. 5 ).
The relationship between IAP level at 2 months after radical nephrectomy and the prognosis was also studied, (Fig. 6) . Our study of the postoperative changes in IAP suggested that it could be used to indicate the presence of recurrence or metastasis. However, IAP production is also stimulated by various inflammatory conditions and the level of this acute phase reactant is effected by surgery, infection and collagen diseases 13,22). In conclusion, srum IAP level can be used as a prognostic marker for RCC, and also provides a tool for the early detection of recurrence or metastasis.
